Appeal a GLP-1 denial, in your state's own words
The sentence that moves a prior-authorization decision is the plan's own criterion quoted back at it. So this fills the letter from what your Medicaid program published — the BMI threshold, the drug you have to try first, the continuation rule — rather than from a generic template that argues in the abstract.
No model writes any of it. Every clinical sentence is fixed text or a figure you typed, because a letter you sign is the last place an invented number belongs.
Your letter
Built from your state's own criteria. Nothing in it is written by a model.
[Your name] Member ID: [your member ID] Re: Appeal of prior-authorization denial for Wegovy Denial dated: [date on the denial notice] To the appeals department, I am appealing the denial of coverage for Wegovy. I am asking for a full reconsideration, and if the denial stands, for this letter to be treated as a request for a fair hearing. The state's published BMI criterion is: Adults 30 or more, or 27 to 29 with at least one weight-related comorbidity — hypertension confirmed by claims history, hyperlipidemia, glucose dysregulation, sleep apnea confirmed by a sleep study, cardiovascular disease or non-alcoholic fatty liver disease. At 12–17 Saxenda needs body weight above 60 kg and a BMI of 30 or more; Wegovy needs a BMI above the 95th percentile for age and sex. My documented BMI is recorded in the enclosed chart notes, measured by my prescriber, and the documentation is enclosed so the plan can check it against that criterion. If the figure on file is older than the measurement enclosed, I ask that the current one be used. For the record, the plan's own continuation rule is: A loss of 5% or more of body weight buys another 6 months. A loss of 1 to 4% can buy 3 months, but only where titration was delayed by intolerance, hospitalization or illness, or another non-scale goal was met. Under 1% is a denial. Once at goal or under a BMI of 25 the request moves to maintenance, also 6 months, which asks that weight stay within 15% of the goal BMI. Adherence means three claims in the past 105 days. Please send the specific criterion relied on, and the clinical basis for the decision, in writing. I am enclosing my prescriber's chart notes in support. I am filing within the deadline printed on the notice. Federal Medicaid rules give a managed care plan's member 60 days from the notice to appeal to the plan, and let a state allow up to 90 days to request a fair hearing on its own decision. Where I request review within 10 days of the notice, my existing benefits continue while it is decided, and I am asking that this be honored here. The criteria referred to above are the plan's own, published in Anti-obesity Select Agents PA Criteria (https://medicaid.ms.gov/wp-content/uploads/2024/03/Anti-obesity-Select-Agents-PA-Criteria-3_12_2024.V3.pdf). Thank you for reviewing this. [Your name] [Date]
Before you send it
- Attach your prescriber's chart notes. A letter without them is an assertion; with them it is a record the plan has to answer.
- Check the date and the deadline on the denial notice — the clock runs from that date, not from when you opened the envelope.
- If you are mid-treatment and want your supply to continue, the request has to go in within 10 days.
- This covers Medicaid. Employer and marketplace plans run on different clocks — 180 days for the internal appeal, four months for external review — and the letter's state-criteria paragraph does not apply to them.
What your own plan publishes
An appeal is judged against the criteria the plan wrote, not against a general rule. Each of these sets out what that payer asks for, which document settles it, and where its published policy is.
Which approval a weight-loss exclusion cannot reach — a plan that excludes obesity treatment may still cover the same drug under its cardiovascular or sleep-apnea indication.
The criteria this fills from
Read from each program's own published document, with the date on it. The other 29 programs are on the coverage page with what is known about each.
Questions
- Does appealing work?
- Often enough to be worth an hour. Most GLP-1 denials are procedural — a BMI measured too long ago, a step drug the plan cannot see a record of, a request filed against the obesity indication when the patient also has sleep apnea. Those are fixed by documentation, not by argument. A denial that rests on the state genuinely excluding weight-loss drugs is the one that will not move, and this page tells you which of the two you have.
- Is this legal advice?
- No. It is a letter template filled in with what your state's Medicaid program published, plus two federal rules that apply everywhere: the fair-hearing window and the continued-benefits rule. Your prescriber's chart notes do the clinical work; the letter's job is to point at the exact criterion and ask for a written answer.
- Why does the letter ask them to state the criterion in writing?
- Because a denial that names no criterion cannot be appealed properly, and asking forces the plan to commit to one. It also produces the document you need if the case goes to a fair hearing, where the question is whether the plan applied its own published rule.
- How long do I have?
- The notice states your deadline, and it can be shorter than you expect. In a managed care plan — where most Medicaid members are — you have 60 days from the notice to appeal to the plan first, and a state fair hearing comes after its decision, within 120 days of it (42 CFR 438.402 and 438.408). Where the state made the decision itself, federal rules let it allow up to 90 days to request a fair hearing — a ceiling, not a minimum (42 CFR 431.221). Request review within 10 days of the notice and benefits you were already receiving continue while it is decided, which matters if you are mid-titration.
- Does anything I type here get sent to you?
- No. The letter is assembled in your browser from data already on the page. There is no account, no upload and no server call — which is deliberate on a page where the natural thing to type is a member ID and a diagnosis.